Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy and Picato for Actinic Keratosis
NCT01541553Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Mar 2012
- Primary completion
- Jul 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in actinic keratosis (AK) comparing Picato Arm with Vehicle Arm (2 arms). Primary endpoint: Complete Clearance of AKs at Week 11. Started Mar 2012; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01541553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541553.